After intravenous infusion of CGRP at a dose able to induce vasodilation, 66% of migraineurs experienced a migraine-like headache [94,95,96]; yet, patients with no previous history of migraine only suffered mild headaches [97]. This evidence concerns the gene CALCA and migraine disorder.